A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker

SIMPLE SUMMARY: Molecular target therapy, i.e., antiangiogenesis with bevacizumab, was found to be effective in some patients of epithelial ovarian cancer. Considering the cost, potential adverse effects, including hypertension, proteinuria, bleeding, thromboembolic events, poor wound healing and ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ching-Wei, Lee, Yu-Ching, Chang, Cheng-Chang, Lin, Yi-Jia, Liou, Yi-An, Hsu, Po-Chao, Chang, Chun-Chieh, Sai, Aung-Kyaw-Oo, Wang, Chih-Hung, Chao, Tai-Kuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996991/
https://www.ncbi.nlm.nih.gov/pubmed/35406422
http://dx.doi.org/10.3390/cancers14071651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996991/
https://www.ncbi.nlm.nih.gov/pubmed/35406422
http://dx.doi.org/10.3390/cancers14071651

Ejemplares similares